Tech Stocks Lead Steep Selloff as AI Hype Fades Worldwide Today
Global markets slide as tech shares drop on fading AI chip optimism. Analysts warn the downturn could spill into broa...
Ways To Get Cash Fast For Bills
Learn effective ways to get cash quickly to cover your bills. Take control of your finances with these tips!
21,585 articles
Etsy Director Melissa Reiff: Insider Trade Insight
An unexpected move by Etsy’s board member sparked questions about insider trading activity. This article breaks down ...
Wayfair’s Stock Sinks as Investors Worry Expansion Plans
Wayfair reported a quarterly loss and warned margins could shrink as it accelerates expansion. Investors responded wi...
Opendoor Technologies Jumps on IBuying Surge: What It Means
Opendoor Technologies reports a sharp uptick in iBuying activity, with 1,706 homes bought in the latest quarter, lift...
Bitcoin Ticks Higher Markets as Traders Weigh Trump Address
As markets digest a high-stakes political address and evolving risk appetite, bitcoin nudges higher. Traders balance ...
Live: Will CoreWeave Soar After Q4 Earnings Tonight
CoreWeave is set to report Q4 2025 results after the close, with investors weighing 2026 guidance amid a legal backdr...
The Other Schwab Dividend Having a Growing Moment Now
The spotlight isn’t only on SCHD. Schwab’s international dividend ETF SCHY is quietly stealing the show for investors...
ATTOM Says Rental Yields Are Slipping Across Most Counties
A new ATTOM report shows rental yields are falling in the majority of U.S. counties as high home prices squeeze inves...
Magnificent News: Microsoft Rebounds as AI Bets Rally
Microsoft led a rebound among the Magnificent 7 as investors rotated back into software, while Apple and Alphabet sli...
Barclays Raises Hims & Hers Target After Novo Deal Clears
Barclays boosts its target on Hims & Hers Health as Novo Nordisk deal removes a key legal overhang, while Progyny see...
Schd Dgro 2026: Numbers Point to a Surprising Winner
Early 2026 data shows SCHD pulling ahead of VYM and DGRO in total return and dividend growth, signaling a potential s...
Analyst Thinks Johnson & Johnson Could Hit a $280 Target
A major analyst raises the price target on Johnson & Johnson to $280, arguing growing oncology sales and a planned sp...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status